| NCT ID | NCT07266675 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mackay Memorial Hospital |
| Condition | Cardiogenic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2024-07-19 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2024-07-19 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Epidemiology studies showed that the burden of cardiogenic shock (CS) persistently high, with increasing annual medical expenses and steady prevalence. In-hospital and one-year mortality reduce annually. Hence, there are increasing number of patients who survive to hospital discharge but they will face further challenges in the subacute stage after hospital discharge. However, there are still insufficient studies focusing on this issue. Establishment of a healthcare neatwork to help hospital survivors of CS return society safely is critical.
Eligibility Criteria
Inclusion Criteria: Hospital survivors of cardiogenic shock Exclusion Criteria: * Age \< 18 years。 * Patient or family refuse follow-up. * Patient died within hospital stay.
Contact & Investigator
Cardiovascular department
PRINCIPAL INVESTIGATOR
Mackay Memorial Hospital
Frequently Asked Questions
Who can join the NCT07266675 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiogenic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07266675 currently recruiting?
Yes, NCT07266675 is actively recruiting participants. Contact the research team at sjay6277@gmail.com for enrollment information.
Where is the NCT07266675 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07266675 clinical trial?
NCT07266675 is sponsored by Mackay Memorial Hospital. The principal investigator is Cardiovascular department at Mackay Memorial Hospital. The trial plans to enroll 350 participants.